Citation: Sr. Weiss et al., CANCER RECURRENCES AND 2ND PRIMARY CANCERS AFTER USE OF ANTIHISTAMINES OR ANTIDEPRESSANTS, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 594-599
Authors:
CHRISTIAN MC
PLUDA JM
HO PTC
ARBUCK SG
MURGO AJ
SAUSVILLE EA
Citation: Mc. Christian et al., PROMISING NEW AGENTS UNDER DEVELOPMENT BY THE DIVISION OF CANCER-TREATMENT, DIAGNOSIS, AND CENTERS OF THE NATIONAL-CANCER-INSTITUTE, Seminars in oncology, 24(2), 1997, pp. 219-240
Citation: M. Smith et Ptc. Ho, PEDIATRIC DRUG DEVELOPMENT - A PERSPECTIVE FROM THE CANCER-THERAPY EVALUATION PROGRAM (CTEP) OF THE NATIONAL-CANCER-INSTITUTE (NCI), Investigational new drugs, 14(1), 1996, pp. 11-22
Authors:
HO PTC
ZIMMERMAN K
WEXLER LH
BLANEY S
JAROSINSKI P
WEAVERMCCLURE L
IZRAELI S
BALIS FM
Citation: Ptc. Ho et al., A PROSPECTIVE EVALUATION OF IFOSFAMIDE-RELATED NEPHROTOXICITY IN CHILDREN AND YOUNG-ADULTS, Cancer, 76(12), 1995, pp. 2557-2564
Authors:
HO PTC
ESTROFF JA
KOZAKEWICH H
SHAMBERGER RC
LILLEHEI CW
GRIER HE
DILLER L
Citation: Ptc. Ho et al., PRENATAL DETECTION OF NEUROBLASTOMA - A 10-YEAR EXPERIENCE FROM THE ANA-FARBER-CANCER-INSTITUTE-AND-CHILDRENS-HOSPITAL, Pediatrics, 92(3), 1993, pp. 358-364